Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients
about
The Kell protein of the common K2 phenotype is a catalytically active metalloprotease, whereas the rare Kell K1 antigen is inactive. Identification of novel substrates for the Kell proteinKell and XK immunohistochemistry in McLeod myopathyTranscriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cellsAblation of the Kell/Xk complex alters erythrocyte divalent cation homeostasisAssociation of XK and Kell blood group proteinsCaspase-mediated activation of Caenorhabditis elegans CED-8 promotes apoptosis and phosphatidylserine externalizationMcLeod syndrome: a neurohaematological disorder.Red cell antigens: Structure and function.Two McLeod patients with novel mutations in XK.The human Kell blood group binds the erythroid 4.1R protein: new insights into the 4.1R-dependent red cell membrane complex.Xkr8 phospholipid scrambling complex in apoptotic phosphatidylserine exposure.Expression profiles of mouse Kell, XK, and XPLAC mRNA.Insights into the structure and function of membrane polypeptides carrying blood group antigens.A spontaneous novel XK gene mutation in a patient with McLeod syndrome.A historical perspective on the discovery of the Kell blood group carriers.Onset of expression of the components of the Kell blood group complex.Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM.Point mutations causing the McLeod phenotype.
P2860
Q24298076-741B4C70-01C4-48C5-8D8D-3D8935A40403Q28216565-320F6233-925F-4DED-9EFF-B16B96318441Q28364279-DE3E47A5-352A-451A-9ACA-7AB201F9AD0AQ28594902-93FBF773-F79D-455B-862A-B3417D38C183Q28611170-9350AF8C-9909-431C-B02E-2777EF55812AQ34384760-D8BAAC68-BA28-4F97-BC98-0FF8CA983063Q34660441-771B3AAD-A863-4624-86BA-4E701AA8D592Q35199789-277A1C34-8075-47C7-AAB0-242D209EA515Q35915942-BC1452FC-8C9C-4B1A-80E0-C6106033775AQ36469748-602C94DA-7BB0-4738-A637-144787963468Q37213809-9D4590E0-B1E7-4BA1-A3E7-A9D7E1535934Q40190251-9791B789-73B6-4413-8C6E-0BE3EB53FF44Q40846483-5210950D-B7DA-4964-A19E-32AF068CDDDBQ43795706-CC518BB4-63E0-4E15-9B46-0BD89A9BC071Q44493454-644E39FC-D5AC-47ED-B0E3-960038C2D2FDQ46526707-22DD1971-5566-400A-90B1-DF548ADA6066Q50723626-E82296D1-E5ED-4E1F-9BA8-1ABF2F74E382Q52545894-8E831D30-6D23-4DB2-90B2-C864613D0085
P2860
Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Purification and partial chara ...... n deficient in McLeod patients
@ast
Purification and partial chara ...... n deficient in McLeod patients
@en
Purification and partial chara ...... n deficient in McLeod patients
@en-gb
Purification and partial chara ...... n deficient in McLeod patients
@nl
type
label
Purification and partial chara ...... n deficient in McLeod patients
@ast
Purification and partial chara ...... n deficient in McLeod patients
@en
Purification and partial chara ...... n deficient in McLeod patients
@en-gb
Purification and partial chara ...... n deficient in McLeod patients
@nl
prefLabel
Purification and partial chara ...... n deficient in McLeod patients
@ast
Purification and partial chara ...... n deficient in McLeod patients
@en
Purification and partial chara ...... n deficient in McLeod patients
@en-gb
Purification and partial chara ...... n deficient in McLeod patients
@nl
P2093
P1433
P1476
Purification and partial chara ...... n deficient in McLeod patients
@en
P2093
D Blanchard
D Goossens
J P Cartron
O Bertrand
S Khamlichi
P2860
P356
10.1111/J.1432-1033.1995.TB20342.X
P407
P577
1995-03-15T00:00:00Z